| 1 | Centanafadine In Adults With Attention-Deficit Hyperactivity Disorder | 2024-006-B |  |
| 2 | Transcranial Photobiomodulation Helmet For Motor Signs Of Parkinson’s Disease | 2024-005-B | |
| 3 | Toludesvenlafaxine Hydrochloride (Ly03005) For Major Depressive Disorder | 2024-003-B | |
| 4 | Etrasimod for Ulcerative Colitis | 2024-002-B | |
| 5 | Misha Knee System For Mild-To-Moderate Medial Knee Osteoarthritis | 2024-001-B | |
| 6 | Donanemab In Early Alzheimer’s Disease | 2023-008-B | |
| 7 | GB-0998 For Unexplained Recurrent Miscarriage | 2023-005-S | |
| 8 | Airway Shield | 2023-004-S | |
| 9 | Capivasertib For Breast Cancer | 2023-002-B | |
| 10 | Baxdrostat In Patients With Resistant Hypertension | 2023-001-S | |
| 11 | Aprocitentan In Patients With Resistant Hypertension | 2023-001-B | |
| 12 | Tirzepatide For Treatment Of Obesity | 2022-010-S | |
| 13 | Oral Medication For Treatment Of Obstructive Sleep Apnoea | 2022-010-B | |
| 14 | The Mirvie RNA Platform For Early Detection Of Pre-Eclampsia | 2022-009-S | |
| 15 | GammaSense for Alzheimer's disease | 2022-009-B | |
| 16 | Extravascular Implantable Cardioverter-Defibrillator | 2022-008-B | |
| 17 | Obefazimod (ABX464) For The Treatment Of Ulcerative Colitis | 2022-007-B | |
| 18 | Nirsevimab For Prevention Of Respiratory Syncytial Virus In Infants | 2022-006-B | |
| 19 | Etrolizumab For Inflammatory Bowel Disease | 2022-005-S | |
| 20 | Rewalk Reboot Soft Exoskeleton Device In Stroke Paraplegia Patients | 2022-005-B | |
| 21 | Tebipenem Pivoxil Hydrobromide In Complicated Urinary Tract Infection | 2022-004-S | |
| 22 | Automated Virtual Reality Cognitive Therapy (Gamechange) For Agoraphobia Among Psychiatric Patients | 2022-004-B | |
| 23 | Automated Virtual Reality Cognitive Therapy (gameChange) for Agoraphobia among Psychiatric Patients | 2022-004-B | |
| 24 | Peripheral Blood Stem Cell (PBSC) For Articular Cartilage Regeneration (An Update) | 2022-003-S | |
| 25 | Lecanemab (BAN2401) For Alzheimer's Disease | 2022-003-B | |